{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:08:30Z","timestamp":1761491310868,"version":"3.37.3"},"reference-count":28,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2021,11,1]]},"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1136\/ejhpharm-2021-002756","type":"journal-article","created":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T18:20:13Z","timestamp":1636741213000},"page":"72-78","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Potential impact of national recommendations to use short course antibiotic therapy on antibiotic use in the emergency department of a UK hospital: retrospective observational study"],"prefix":"10.1136","volume":"29","author":[{"given":"Neil","family":"Powell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liam","family":"Wade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rumaysah","family":"Iqbal-elahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Philips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhys","family":"Owens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amani","family":"Amir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy","family":"Nampa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3242-9544","authenticated-orcid":false,"given":"Kevin","family":"Tai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Jadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,11,12]]},"reference":[{"key":"2024102217112476000_29.2.72.1","unstructured":"World Health Organization . Antimicrobial resistance: global report on surveillance 2014. WHO, 2014."},{"key":"2024102217112476000_29.2.72.2","unstructured":"Public Health England . English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report. PHE publication gateway reference: GW-687, 2019."},{"key":"2024102217112476000_29.2.72.3","unstructured":"HM Government . Department of Health and Social Care. Tackling antimicrobial resistance 2019\u20132024: The UK\u2019s five-year national action plan [Internet], 2019. Available: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/784894\/UK_AMR_5_year_national_action_plan.pdf"},{"key":"2024102217112476000_29.2.72.4","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2016.3646","article-title":"The new antibiotic mantra-\"shorter is better\"","volume":"176","author":"Spellberg","year":"2016","journal-title":"JAMA Intern Med"},{"key":"2024102217112476000_29.2.72.5","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2016.3633","article-title":"Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial","volume":"176","author":"Uranga","year":"2016","journal-title":"JAMA Intern Med"},{"key":"2024102217112476000_29.2.72.6","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2017.1938","article-title":"Association of adverse events with antibiotic use in hospitalized patients","volume":"177","author":"Tamma","year":"2017","journal-title":"JAMA Intern Med"},{"key":"2024102217112476000_29.2.72.7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir301"},{"key":"2024102217112476000_29.2.72.8","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/cid\/ciy1054","article-title":"Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: a noninferiority randomized controlled trial","volume":"69","author":"Yahav","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2024102217112476000_29.2.72.9","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.15.1669"},{"key":"2024102217112476000_29.2.72.10","unstructured":"NICE . Otitis media (acute): antimicrobial prescribing NICE guideline, 2018."},{"key":"2024102217112476000_29.2.72.11","unstructured":"NICE guideline . Human and animal bites: antimicrobial prescribing. draft for consultation, 2019."},{"key":"2024102217112476000_29.2.72.12","unstructured":"NICE . Pyelonephritis (acute): antimicrobial prescribing NICE guideline, 2018."},{"key":"2024102217112476000_29.2.72.13","unstructured":"NICE . Urinary tract infection (lower): antimicrobial prescribing. NICE guideline, 2018."},{"key":"2024102217112476000_29.2.72.14","unstructured":"NICE . Cellulitis and erysipelas: antimicrobial prescribing NICE guideline, 2019."},{"key":"2024102217112476000_29.2.72.15","unstructured":"NICE . Cough (acute): antimicrobial prescribing. NICE guideline, 2019."},{"key":"2024102217112476000_29.2.72.16","unstructured":"NICE . Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing NICE guideline, 2018."},{"key":"2024102217112476000_29.2.72.17","unstructured":"NICE . Pneumonia (community-acquired): antimicrobial prescribing. NICE guideline, 2019."},{"key":"2024102217112476000_29.2.72.18","unstructured":"NICE . Pneumonia (hospital-acquired): antimicrobial prescribing NICE guideline, 2019."},{"key":"2024102217112476000_29.2.72.19","unstructured":"NICE . Diverticular disease: diagnosis and management. NICE guideline, 2019."},{"key":"2024102217112476000_29.2.72.20","unstructured":"NICE . Sore throat (acute): antimicrobial prescribing. NICE guideline, 2018."},{"key":"2024102217112476000_29.2.72.21","unstructured":"NICE . Sinusitis (acute): antimicrobial prescribing. NICE guideline, 2017."},{"key":"2024102217112476000_29.2.72.22","unstructured":"Public Health England . AMR local indicators: Antibiotic Prescribing [Internet]. Fingertips, 2019. Available: https:\/\/fingertips.phe.org.uk\/profile\/amr-local-indicators\/data#page\/3\/gid\/1938132909\/pat\/158\/par\/NT_trust\/ati\/118\/are\/REF\/iid\/93555\/age\/1\/sex\/4"},{"key":"2024102217112476000_29.2.72.23","unstructured":"Stani Beni M , Milani R , Monnier AA . On behalf of the DRIVE-AB WP1 group. metrics for quantifying antibiotic use in the hospital setting: results from a systematic review and international multidisciplinary consensus procedure. J Antimicrob Chemother 2018;73."},{"key":"2024102217112476000_29.2.72.24","unstructured":"World Health Organization . Defined daily dose. Available: https:\/\/www.who.int\/medicines\/regulation\/medicines-safety\/toolkit_ddd\/en\/ [Accessed 6 Sep 2020]."},{"key":"2024102217112476000_29.2.72.25","unstructured":"Excel . Sant Rosa. California: Microsoft, 2010."},{"key":"2024102217112476000_29.2.72.26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l440"},{"key":"2024102217112476000_29.2.72.27","doi-asserted-by":"publisher","DOI":"10.1086\/586749"},{"key":"2024102217112476000_29.2.72.28","doi-asserted-by":"crossref","unstructured":"Schuetz P , Wirz Y , Sager R . Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev 2017;2019.doi:10.1002\/14651858.CD007498.pub3","DOI":"10.1002\/14651858.CD007498.pub3"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2021-002756","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:13:29Z","timestamp":1729642409000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2021-002756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,12]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2,21]]},"published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1136\/ejhpharm-2021-002756"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2021-002756","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"type":"print","value":"2047-9956"},{"type":"electronic","value":"2047-9964"}],"subject":[],"published":{"date-parts":[[2021,11,12]]}}}